FindTrial
Sign In

Role of adiponectin in pulmonary arteries endothelium-dependent dilation response of pulmonary thromboembolism.

Role of adiponectin in pulmonary arteries endothelium-dependent dilation response of pulmonary thromboembolism.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCC-12001994
Enrollment
Unknown
Registered
2012-03-06
Start date
2012-01-02
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pulmonary thromboembolism

Interventions

pulmonary thromboembolism:no
normal:no

Sponsors

First Affiliated Hospital, Shenzhen University, Futian District, Shenzhen, Guangdong
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Male or female, 18-65 years of age; 2. informed consent, understanding trial; 3. no contraindications.

Exclusion criteria

Exclusion criteria: Patients refused

Design outcomes

Primary

MeasureTime frame
Pulmonary artery pressure;adiponectin;—

Countries

China

Contacts

Public ContactJin Chang-e
jinchange_1999@yahoo.com.cn+86 13410286248

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026